SINGAPORE – A Health Sciences Authority investigation into the dermal filler AestheFill has found no evidence of product-related safety and quality issues, after a woman lost her vision in the first reported case of its kind in Singapore.
It will also develop an information leaflet for healthcare professionals to explain the risks of the procedure to patients. The results of the chemical and microbiological tests were within specifications, indicating that the product had been manufactured according to required standards and is safe for use, it said.accidental injection of AestheFillHSA classifies dermal fillers as Class D medical devices, which carry the highest risk. AestheFill has been registered in Singapore since Oct 1, 2021.
Entertainment Entertainment Latest News, Entertainment Entertainment Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: The Straits Times - 🏆 8. / 63 Read more »